AlphaCentric Advisors »

Cme shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Cme (CME) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Cme

Tip: Access up to 7 years of quarterly data

All positions including Cme held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cme by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $195k 905 215.29

More positions owned by AlphaCentric Advisors

Pfizer (PFE)
Rithm Capital Corp Com New (RITM)
Harmony Biosciences Hldgs In (HRMY)
United Therapeutics Corporation (UTHR)
Pacira Pharmaceuticals (PCRX)
BioCryst Pharmaceuticals (BCRX)
Galapagos Nv Spon Adr (GLPG)
Argenx Se Sponsored Adr (ARGX)
Two Harbors Inventment Corpo Note 6.250% 1/1
Inari Medical Ord (NARI)
Docgo (DCGO)
Beigene Sponsored Adr (BGNE)
Ellington Financial Inc ellington financ (EFC)
Axsome Therapeutics (AXSM)
MGIC Investment (MTG)

View all positions for AlphaCentric Advisors

Top funds holding Cme

Vanguard Group
Jpmorgan Chase & Co
Bank of New York Mellon
Parnassus Investments
Norges Bank Investment Management
Guardcap Asset Management
Vontobel Asset Management
T. Rowe Price Associates
Fiera Capital Corporation
Neuberger Berman Group
Henderson Group
Raymond James & Associates
Legal & General Group
Massachusetts Financial Services
Goldman Sachs Group

View all funds holding Cme